Reductions in endometriosis-associated pain among elagolix-treated women are consistent across a range of baseline characteristics
article
OA: closed
CC0
⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study found that elagolix treatment effectively reduced endometriosis-associated pain across diverse patient populations, regardless of baseline characteristics.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment 2019
- Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches 2020
- Elagolix in endometriosis-related pain: a profile of its use as approved in the USA 2019
Cited by (3)
- Endometriosis Associated Infertility: A Critical Review and Analysis on Etiopathogenesis and Therapeutic Approaches 2020
- Elagolix in endometriosis-related pain: a profile of its use as approved in the USA 2019
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment 2019
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK